Clinical Trials on Antibody-secreting Cells in Netherlands
Total 1441 results
-
Maastricht Radiation OncologyCompletedGlioma | Glioblastoma | AstrocytomaNetherlands
-
University Medical Center GroningenTerminated
-
Cortendo ABCompletedCushing Syndrome | Cushing DiseaseUnited States, Spain, Netherlands, Poland, Italy, Bulgaria, France, Greece, Hungary, Israel, Romania
-
Maastricht University Medical CenterUnknownMultiple MyelomaNetherlands
-
University Medical Center GroningenCompleted
-
Amsterdam UMC, location VUmcUnknownNSCLC | EGFR-mutation | HER2-expressionNetherlands
-
Erasmus Medical CenterRecruitingNeuroendocrine TumorsNetherlands
-
Eli Lilly and CompanyTerminatedSmall Cell Lung Cancer | SCLC | Carcinoma, Small CellNetherlands, Belgium
-
The Netherlands Cancer InstituteBristol-Myers SquibbActive, not recruitingStage III Skin MelanomaNetherlands
-
Erasmus Medical CenterLudwig Institute for Cancer Research; Dutch Cancer Society; Stichting Coolsingel... and other collaboratorsRecruitingMelanoma | Head and Neck Cancer | Melanoma, UvealNetherlands
-
Hannah Garcia GarridoRecruitingPneumococcal Infections | Chronic Lymphocytic Leukemia | Vaccine-Preventable Diseases | Invasive Pneumococcal Disease, Recurrent IsolatedNetherlands
-
Maastricht Radiation OncologyThe Limburg University FundTerminated
-
The Netherlands Cancer InstituteUniversity of Pavia; Academisch Medisch Centrum - Universiteit van Amsterdam... and other collaboratorsRecruiting
-
Amsterdam UMC, location VUmcBristol-Myers SquibbRecruiting
-
Novartis PharmaceuticalsCompletedCushing's DiseaseItaly, Belgium, Japan, Germany, United Kingdom, Thailand, Spain, France, Netherlands, Turkey, Israel, China, United States, Canada, India, Argentina, Brazil, Peru, Poland, Russian Federation
-
University Medical Center GroningenCompleted
-
Rigel PharmaceuticalsCompletedWarm Antibody Autoimmune Hemolytic AnemiaUnited States, Spain, Canada, Australia, Norway, France, Belarus, Germany, Netherlands, Belgium, United Kingdom, Austria, Czechia, Georgia, Italy, Russian Federation, Serbia, Ukraine, Romania, Denmark, Hungary, Bulgaria
-
Radboud University Medical CenterUnknownGlioblastoma MultiformeNetherlands
-
Academisch Medisch Centrum - Universiteit van Amsterdam...CompletedUrothelial Carcinoma | Ureter Cancer | Urinary Tract CancerNetherlands
-
Amsterdam UMC, location VUmcNot yet recruitingGlioma | Cognitive ImpairmentNetherlands
-
University Medical Center GroningenVHL AllianceCompletedRenal Cell Carcinoma | Von Hippel-Lindau Disease | Pheochromocytoma | Pancreatic Neuroendocrine Tumor | HemangioblastomaNetherlands
-
UMC UtrechtRadboud University Medical Center; University Medical Center Groningen; Maastricht... and other collaboratorsRecruiting
-
Maastricht Radiation OncologyMaastricht University Medical Center; Ziekenhuis Oost-Limburg; Zuyderland Medisch...Active, not recruitingHigh Grade Glioma | Low-grade GliomaNetherlands
-
University Medical Center GroningenCompleted
-
Erasmus Medical CenterRecruitingNeuroendocrine Tumors | Peptide Receptor Radionuclide TherapyNetherlands
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerNetherlands, United Kingdom
-
University Medical Center GroningenUnknown
-
The Netherlands Cancer InstituteUnknownStage IV Skin Melanoma | Eye; MelanomaNetherlands
-
Erasmus Medical CenterRecruiting
-
Rijnstate HospitalUnknownCrohn Disease | Ulcerative Colitis | Immunology | IBD | T Cell Subsets | Immunological ProfilesNetherlands
-
The Netherlands Cancer InstituteBristol-Myers SquibbRecruitingNeoadjuvant Study With Combination Immuno-oncology for Primary Clear Cell Renal Cell Cancer (NESCIO)Renal Cell CarcinomaUnited Kingdom, Netherlands
-
Erasmus Medical CenterRecruiting
-
dr. Tom van der HulleLeiden University Medical CenterRecruitingRenal Cell CarcinomaNetherlands
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedNon Small Cell Lung Cancer | MesotheliomaNetherlands
-
Maastricht Radiation OncologyMaastricht University Medical CenterRecruitingGlioblastoma (GBM)Netherlands
-
Novartis PharmaceuticalsRecruitingGlioblastoma Multiforme | Gastroesophageal Adenocarcinoma | Pancreatic Ductal AdenocarcinomaNetherlands, Spain, Israel, United States, Switzerland
-
Sanquin Research & Blood Bank DivisionsRadboud University Medical Center; Erasmus Medical Center; Academisch Medisch... and other collaboratorsUnknownSickle Cell Disease | AlloimmunizationNetherlands
-
The Netherlands Cancer InstituteRecruitingLocally Advanced, Squamous Cell Carcinoma of the VulvaNetherlands
-
The Netherlands Cancer InstituteRecruitingMetastatic Squamous Cell Carcinoma of the VulvaNetherlands
-
Boehringer IngelheimTerminatedHead and Neck Neoplasms | Carcinoma, Non-Small-Cell LungNetherlands
-
Maastricht Radiation OncologyWithdrawnGlioblastoma Multiforme | Anaplastic Oligoastrocytoma | Anaplastic AstrocytomaNetherlands
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedNon Small Cell Lung Cancer | MesotheliomaNetherlands
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentTerminatedNon Small Cell Lung Cancer | MesotheliomaNetherlands
-
Impaqtt FoundationMemorial Sloan Kettering Cancer Center; Novartis; Pfizer; Leiden University Medical... and other collaboratorsCompletedRenal Cell Carcinoma | Hepatocellular Carcinoma | Gastrointestinal Stromal Tumors | Oral ComplaintsNetherlands
-
Erasmus Medical CenterRecruitingGlioblastomaNetherlands
-
Maastricht Radiation OncologyUniversity Medical Center Groningen; The Netherlands Cancer InstituteCompletedNon Small Cell Lung Cancer (NSCLC) | Stage III Non-Small Cell Lung Cancer | Radical TreatmentNetherlands
-
European Organisation for Research and Treatment...AmgenTerminatedBone Giant Cell TumorSpain, United Kingdom, Italy, Netherlands
-
The Netherlands Cancer InstituteAstraZenecaRecruitingOsimertinib Resistance in Patients With Non-small-cell Lung Carcinoma That Have Progressed. (OSIRIS)Non-small-cell Lung CarcinomaNetherlands
-
Leiden University Medical CenterBoehringer Ingelheim; Chordoma FoundationActive, not recruiting
-
Erasmus Medical CenterRecruitingImmunotherapy | Melanoma Stage IV | Melanoma Stage III | Toxicity, DrugNetherlands